NICE
NICE Ltd.
NasdaqGSUSDEQUITY
Technology
DELAYED
Buy
+52/100
Last price
115.00
▼ 0.83 (0.72%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
116.98
Prev close
115.83
Day high
119.14
Day low
114.94
Volume
387.34K
Market cap
$6.76B
P/E (TTM)
16.79
52W range
83.10 – 140.18
Day trading desk
Gap from prior close
+0.99%
Prior close 115.83
VWAP
115.85
-0.74% from price
Relative volume
1.30×
Normal
Session range
3.65%
114.94 – 119.14
Position in range
1%
Near session low
ATR (14D)
5.76
5.01% of price
Prior day high
116.00
PDH
Prior day low
113.51
PDL
Bid / ask spread
—
Quote not published
Session volume
724.75K
Avg 558.38K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+7.98%
+6.0%
1M
+9.32%
+8.2%
3M
+19.14%
+14.6%
6M
+3.18%
-15.0%
YTD
+2.03%
-12.2%
1Y
-16.55%
-33.0%
3Y
-32.16%
-114.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NICE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
44.11K
Total on file
Fundamentals
Market cap$6.76B
Enterprise value$169.32B
Revenue (TTM)$3.07B
Gross profit$2.00B
EBITDA$815.83M
Net income$425.45M
EPS (TTM)$6.87
Free cash flow$615.30M
Total cash$354.69M
Total debt$88.22M
Book value / share$2.57
Shares outstanding58.60M
Float1.46B
Short % of float2.11%
Dividend yield0.00%
Beta (5Y)0.05
Valuation & profitability ratios
Trailing P/E16.79
Forward P/E9.10
PEG ratio0.77
Price / sales—
Price / book44.89
EV / revenue55.16
EV / EBITDA207.54
Gross margin65.12%
Operating margin13.83%
Profit margin13.86%
Return on equity11.33%
Return on assets6.96%
Debt / equity2.34
Current ratio1.33
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.95B | $2.74B | $2.38B | $2.18B | +7.7% |
| Operating revenue | $2.95B | $2.74B | $2.38B | $2.18B | +7.7% |
| Cost of revenue | $989.25M | $909.52M | $768.17M | $683.69M | +8.8% |
| Gross profit | $1.96B | $1.83B | $1.61B | $1.50B | +7.1% |
| Research & development | $360.45M | $360.61M | $322.71M | $306.07M | -0.0% |
| Selling, general & admin | $949.94M | $919.19M | $851.40M | $856.36M | +3.3% |
| Total operating expense | $1.31B | $1.28B | $1.17B | $1.16B | +2.4% |
| Operating income | $645.76M | $545.95M | $435.23M | $335.17M | +18.3% |
| Net interest income | $50.60M | $59.71M | $25.95M | $9.89M | -15.3% |
| Pre-tax income | $704.02M | $604.83M | $457.70M | $345.33M | +16.4% |
| Tax provision | $91.92M | $162.24M | $119.40M | $79.39M | -43.3% |
| Net income | $612.10M | $442.59M | $338.30M | $265.94M | +38.3% |
| Net income to common | $612.10M | $442.59M | $338.30M | $265.94M | +38.3% |
| Basic EPS | 9.82 | 6.97 | 5.32 | 4.17 | +40.9% |
| Diluted EPS | 9.67 | 6.76 | 5.11 | 4.00 | +43.0% |
| EBIT | $704.02M | $604.98M | $461.40M | $349.05M | +16.4% |
| EBITDA | $903.06M | $810.00M | $628.76M | $525.59M | +11.5% |
| Basic shares | 62.33M | 63.48M | 63.59M | 63.79M | -1.8% |
| Diluted shares | 63.32M | 65.51M | 66.27M | 66.47M | -3.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $379.39M | $481.71M | $511.80M | $529.60M | — | -21.2% |
| Cash & short-term investments | $417.40M | $1.62B | $1.41B | $1.57B | — | -74.3% |
| Accounts receivable | $737.95M | $643.99M | $585.15M | $518.52M | — | +14.6% |
| Total current assets | $1.38B | $2.50B | $2.31B | $2.42B | — | -44.9% |
| Property, plant & equipment | $267.46M | $278.38M | $278.98M | $262.18M | — | -3.9% |
| Goodwill & intangibles | $3.03B | $2.08B | $2.13B | $1.83B | — | +45.5% |
| Total assets | $5.11B | $5.30B | $5.12B | $4.85B | — | -3.6% |
| Total current liabilities | $887.63M | $1.47B | $1.12B | $1.14B | — | -39.8% |
| Current debt | — | $458.79M | $209.23M | $209.29M | $395.95M | — |
| Long-term debt | — | — | $457.08M | $455.38M | $429.27M | — |
| Total debt | $88.80M | $563.60M | $782.97M | $777.46M | — | -84.2% |
| Total liabilities | $1.23B | $1.69B | $1.76B | $1.80B | — | -27.4% |
| Retained earnings | $3.31B | $2.70B | $2.26B | $1.93B | — | +22.7% |
| Shareholder equity | $3.88B | $3.59B | $3.34B | $3.04B | — | +8.0% |
| Working capital | $491.50M | $1.03B | $1.19B | $1.28B | — | -52.3% |
| Net tangible assets | $848.40M | $1.51B | $1.21B | $1.22B | — | -43.8% |
| Shares issued | 74.77M | 74.77M | 74.77M | 74.77M | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $612.10M | $442.59M | $338.30M | $265.94M | +38.3% |
| Depreciation & amortisation | $199.04M | $205.02M | $167.36M | $176.55M | -2.9% |
| Stock-based compensation | $146.05M | $182.07M | $176.66M | $182.70M | -19.8% |
| Change in working capital | -$250.10M | $49.59M | -$76.30M | -$107.16M | -604.4% |
| Operating cash flow | $716.55M | $832.64M | $561.43M | $479.71M | -13.9% |
| Capital expenditure | -$93.75M | -$99.77M | -$84.18M | -$81.89M | +6.0% |
| Investing cash flow | $159.96M | -$397.40M | -$293.58M | -$152.35M | +140.3% |
| Share buybacks | -$488.91M | -$369.20M | -$288.44M | -$144.94M | -32.4% |
| Financing cash flow | -$984.27M | -$456.60M | -$290.27M | -$164.50M | -115.6% |
| Free cash flow | $622.80M | $732.87M | $477.25M | $397.82M | -15.0% |
| End cash position | $382.01M | $485.03M | $513.31M | $533.10M | -21.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $782.29M | $768.62M | $786.50M | $732.00M | $726.71M | +1.8% |
| Operating revenue | $782.29M | $768.62M | $786.50M | $732.00M | $726.71M | +1.8% |
| Cost of revenue | $281.28M | $273.82M | $272.64M | $242.93M | $241.60M | +2.7% |
| Gross profit | $501.01M | $494.80M | $513.85M | $489.07M | $485.11M | +1.3% |
| Research & development | $102.83M | $97.48M | $91.12M | $90.46M | $89.76M | +5.5% |
| Selling, general & admin | $294.18M | $270.57M | $246.51M | $237.83M | $234.76M | +8.7% |
| Total operating expense | $397.01M | $368.05M | $337.63M | $328.30M | $324.52M | +7.9% |
| Operating income | $104.00M | $126.75M | $176.22M | $160.77M | $160.59M | -17.9% |
| Net interest income | $3.61M | $19.32M | $6.45M | $21.14M | $14.82M | -81.3% |
| Pre-tax income | $107.61M | $146.07M | $182.68M | $181.91M | $175.41M | -26.3% |
| Tax provision | $24.38M | $99.25M | $32.12M | $37.06M | -$11.99M | -75.4% |
| Net income | $83.23M | $46.81M | $150.55M | $144.85M | $187.40M | +77.8% |
| Net income to common | $83.23M | $46.81M | $150.55M | $144.85M | $187.40M | +77.8% |
| Basic EPS | 1.41 | 0.78 | 2.44 | 2.33 | 3.01 | +80.8% |
| Diluted EPS | 1.40 | 0.77 | 2.41 | 2.29 | 2.96 | +81.8% |
| EBIT | $104.00M | $126.75M | $176.22M | $160.77M | $160.59M | -17.9% |
| EBITDA | $166.37M | $188.59M | $238.30M | $209.69M | $205.20M | -11.8% |
| Basic shares | 58.82M | 59.92M | 61.80M | 62.04M | 62.16M | -1.8% |
| Diluted shares | 59.39M | 60.60M | 62.58M | 63.16M | 63.21M | -2.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $315.38M | $257.54M | $379.39M | $418.05M | $535.05M | — | +22.5% |
| Cash & short-term investments | $354.69M | $304.07M | $417.40M | $455.89M | $1.63B | — | +16.6% |
| Accounts receivable | $836.59M | $767.27M | $737.95M | $714.91M | $680.96M | — | +9.0% |
| Total current assets | $1.47B | $1.30B | $1.38B | $1.38B | $2.54B | — | +12.8% |
| Property, plant & equipment | $278.70M | $269.94M | $267.46M | $264.98M | $254.92M | — | +3.2% |
| Goodwill & intangibles | $2.95B | $2.99B | $3.03B | $3.06B | $2.06B | — | -1.1% |
| Total assets | $5.12B | $4.98B | $5.11B | $5.15B | $5.31B | — | +2.8% |
| Total current liabilities | $1.10B | $1.06B | $887.63M | $980.24M | $1.38B | — | +4.0% |
| Current debt | — | — | — | — | $459.64M | $459.21M | — |
| Total debt | $88.22M | $86.08M | $88.80M | $86.85M | $539.03M | — | +2.5% |
| Total liabilities | $1.34B | $1.31B | $1.23B | $1.29B | $1.58B | — | +2.8% |
| Retained earnings | — | — | $3.31B | — | — | — | — |
| Shareholder equity | $3.78B | $3.68B | $3.88B | $3.86B | $3.73B | — | +2.8% |
| Working capital | $363.54M | $238.90M | $491.50M | $402.73M | $1.15B | — | +52.2% |
| Net tangible assets | $823.35M | $687.41M | $848.40M | $798.32M | $1.67B | — | +19.8% |
| Shares issued | 58.60M | 58.44M | 74.77M | 61.74M | 61.74M | — | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $83.23M | $46.81M | $150.55M | $144.85M | $187.40M | +77.8% |
| Depreciation & amortisation | $62.37M | $61.84M | $62.07M | $48.92M | $44.61M | +0.9% |
| Stock-based compensation | $52.67M | $35.39M | $29.57M | $35.83M | $37.31M | +48.8% |
| Change in working capital | -$82.60M | $126.38M | -$82.85M | -$61.78M | -$200.22M | -165.4% |
| Operating cash flow | $122.66M | $179.25M | $179.66M | $190.50M | $61.32M | -31.6% |
| Capital expenditure | -$29.54M | -$30.46M | -$23.68M | -$26.92M | -$22.72M | +3.0% |
| Investing cash flow | -$22.25M | -$39.01M | -$53.25M | $195.72M | $29.01M | +43.0% |
| Share buybacks | -$57.95M | -$253.25M | -$165.19M | -$40.55M | -$30.84M | +77.1% |
| Financing cash flow | -$47.25M | -$255.66M | -$165.11M | -$500.54M | -$30.51M | +81.5% |
| Free cash flow | $93.12M | $148.79M | $155.98M | $163.58M | $38.61M | -37.4% |
| End cash position | $319.17M | $263.71M | $382.01M | $420.17M | $536.57M | +21.0% |
Options analytics
Put / call volume
1.04
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
70.00
-39.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
305
Contracts, this expiry
Put volume
317
Contracts, this expiry
Heaviest call OI
90.00
0 contracts
Heaviest put OI
70.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.64 | 2.70 | +2.3% |
| Mar 2026 | 2.52 | 2.64 | +4.8% |
| Dec 2025 | 3.21 | 3.24 | +0.8% |
| Sep 2025 | 3.17 | 3.18 | +0.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.78 | 13 | $785.74M | +7.3% |
| Next quarter | 3.07 | 13 | $844.87M | +7.4% |
| Current year | 11.17 | 14 | $3.18B | +8.0% |
| Next year | 12.67 | 14 | $3.47B | +9.1% |
Analyst targets & ownership
Mean target$132.77
High target$170.00
Low target$100.00
Implied upside15.45%
Analyst count13
ConsensusBUY
Strong buy / Buy3 / 6
Hold5
Sell / Strong sell0 / 0
Held by insiders0.00%
Held by institutions62.77%
Institutions holding430
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
113.29
+1.51% from price
SMA 20
109.36
+5.46% from price
SMA 50
105.13
+9.71% from price
SMA 100
99.05
+16.10% from price
SMA 200
104.93
+9.91% from price
EMA 12
112.52
+2.21% from price
EMA 26
109.44
+5.08% from price
EMA 50
106.07
+8.42% from price
RSI (14)
58.8
Neutral
MACD (12,26,9)
3.07
Hist 0.28
ATR (14)
5.76
4.99% of price
Realised vol 30D
50.0%
Annualised
Bollinger upper
122.15
20, 2σ
Bollinger lower
96.57
20, 2σ
50 / 200 cross
Golden
105.13 vs 104.93
Trend bias
Above 200
+9.91%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.28
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
50.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.8%
Peak to trough
Max drawdown 5Y
-73.6%
Peak to trough
ATR 14
5.76
4.99% of price
Beta (reported)
0.05
5Y monthly, from filing
Short interest
Shares short
1.23M
Prior 1.49M
Change vs prior
-17.8%
Shorts covering
% of float
2.11%
Normal
% of shares out
2.10%
Against total outstanding
Days to cover
3.1
Liquid
Float
1.46B
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Oppenheimer | UPGRADE | Perform | Outperform |
| Sep 24, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Morgan Stanley | DOWNGRADE | Overweight | Equal-Weight |
| Jun 18, 26 | DA Davidson | UPGRADE | Neutral | Buy |
| Jun 10, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jun 10, 26 | Wedbush | MAINTAINED | Neutral | Neutral |
| Jun 10, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
| Jun 10, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| May 11, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 8, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield0.70%
Payout ratio0.00%
Ex-dividend dateFeb 23, 2017
Next pay dateMar 15, 2017
Last split2:1
Split dateMay 31, 2006
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-09
Corporate Changes & Voting Matters
6-K · 2026-08-06
Corporate Changes & Voting Matters
6-K · 2026-08-05
Corporate Changes & Voting Matters
6-K · 2026-07-08
Corporate Changes & Voting Matters
6-K · 2026-06-09
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-26
Corporate Changes & Voting Matters
6-K · 2026-05-18
Corporate Changes & Voting Matters
6-K · 2026-05-07
Headlines
NiCE Names Carahsoft Distributor of the Year for 2025
GlobeNewswire · 2d ago
Should You Invest in Nice (NICE) Based on Bullish Wall Street Views?
Zacks · 2d ago
Nice (NICE) Stock Declines While Market Improves: Some Information for Investors
Zacks · 4d ago
NiCE Named a Leader in the IDC MarketScape for Worldwide Agentic Contact Center-as-a-Service Platforms
Business Wire · 6d ago
Target upgraded, Moderna downgraded: Wall Street's top analyst calls
The Fly · 7d ago
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, BankUnited, Ciena Corporation, CoreWeave, Dow, FormFactor, Lumentum Holdings, Moderna, Target, and More
24/7 Wall St. · 7d ago
Nice (NICE) is Attracting Investor Attention: Here is What You Should Know
Zacks · 9d ago
NiCE Named a 2026 Best Workplace for Innovators by Fast Company in the Cybersecurity & Enterprise Category
Business Wire · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.